Benefits and Risks of Colorectal Cancer Screening

Riemann, Jürgen F.; Schröder, Carsten; Kallenbach, Maria; Giersiepen, Klaus; Schmoll, Hans‐Joachim

doi:10.1159/000364886

Cited by 4 publications

(2 citation statements)

References 58 publications

(74 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Colorectal cancer (CRC) is a major public health burden in the United States (USA) [ 1 ], with an estimated 151,030 new cases and 52,580 deaths from the disease expected to occur in 2022 [ 2 ]. Timely screening facilitates the identification and removal of precancerous lesions and prevents the development of CRC [ 3 , 4 ]. Screening also reduces the incidence and mortality from CRC [ 5 , 6 ].…”

Section: Introductionmentioning

confidence: 99%

Evaluation of Colonoscopy and Sigmoidoscopy Utilization for Colorectal Cancer Screening in Georgia, USA

et al. 2022

View full text Add to dashboard Cite

Colorectal cancer (CRC) is the third most prevalent cancer, and the second most common cancer-related cause of death in the United States (USA). Timely screening reduces both CRC incidence and mortality. Understanding population behaviors and factors that influence CRC screening is important for directing interventions targeted at reducing CRC rates. The 1997–2018 Behavioral Risk Factor Surveillance System (BRFSS) data were analyzed for trends in colonoscopy and sigmoidoscopy utilization for CRC screening among adults in Georgia, USA. Overall, in Georgia, there has been an increase in the prevalence of colonoscopy and sigmoidoscopy utilization from 48.1% in 1997 to 71.2% in 2018 (AAPC = 2.30, p < 0.001). Compared nationally, this increase was less pronounced (from 41.0% in 1997 to 73.7% in 2018 (AAPC = 2.90, p < 0.001) overall for USA). Logistic regression analysis of the 2018 BRFSS data, adjusting for sociodemographic factors, shows that sex (female vs. male [aOR = 1.20, C.I. = 1.05, 1.38]); marital status (couple vs. single [aOR = 1.20, C.I. = 1.04, 1.39]); healthcare coverage (yes vs. no [aOR = 3.86, C.I. = 3.05, 4.88]); age (60–69 years [aOR = 2.38, C.I. = 2.02, 2.80], 70–79 [aOR = 2.88, C.I. = 2.38, 3.48] vs. 50–59 years); education (high school [aOR = 1.32, C.I. = 1.05, 1.65], some post high school [aOR= 1.63, C.I. = 1.29, 2.06], college graduate [aOR = 2.08, C.I. = 1.64, 2.63] vs. less than high school); and income ($25,000–$49,999 [aOR = 1.24, C.I. = 1.01, 1.51], $50,000+ [aOR = 1.56, C.I. = 1.27, 1.91] vs. <$25,000) were all significantly associated with colonoscopy and sigmoidoscopy utilization. In Georgia, a significant increase over time in colonoscopy and sigmoidoscopy utilization for CRC screening was observed pertaining to the associated sociodemographic factors. The findings from this study may help guide tailored programs for promoting screening among underserved populations.

show abstract

Section: Introductionmentioning

confidence: 99%

Evaluation of Colonoscopy and Sigmoidoscopy Utilization for Colorectal Cancer Screening in Georgia, USA

et al. 2022

View full text Add to dashboard Cite

show abstract

“…According to the American Cancer Society, 147,950 new cases and 53,200 deaths from CRC were expected to occur in 2020, and the lifetime risk of developing CRC is about 1 in 23 (4.4%) for men and 1 in 25 (4.1%) for women [ 3 ]. Screening for CRC can help identify cancers at an early and potentially curable stage and prevent the development of CRC by allowing the removal of precancerous growths before they become malignant [ 4 , 5 ]. In addition, CRC screening has been shown to improve clinical outcomes such as reducing the incidence and mortality from CRC [ 6 , 7 , 8 , 9 , 10 ].…”

Section: Introductionmentioning

confidence: 99%

Evaluation of Blood Stool Test Utilization for Colorectal Cancer Screening in Georgia, USA

et al. 2021

View full text Add to dashboard Cite

Colorectal cancer (CRC) is the third most prevalent cancer and the second most common cause of cancer-related deaths in the United States (USA). Early screening has been demonstrated to improve clinical outcomes for CRC. Assessing patterns in CRC screening utilization is important for guiding policy and implementing programs for CRC prevention and control. This study examines the trends and sociodemographic factors associated with blood stool test utilization (BSTU) for CRC screening in Georgia, USA. The Behavioral Risk Factor Surveillance System (BRFSS) data were analyzed for Average Annual Percent Change (AAPC) in BSTU between 1997 and 2014 among adults aged 50+ who have had a blood stool test within the past two years, and logistic regression analysis of the 2016 data was performed to identify the associated sociodemographic factors. In Georgia, an overall decrease was observed in BSTU, from 27.8% in 1997 to 16.1% in 2014 (AAPC = −2.6, p = 0.023). The decrease in BSTU was less pronounced in Georgia than nationally (from 26.1% in 1997 to 12.8% in 2014 (AAPC = −4.5, p < 0.001)). BSTU was significantly associated with black race/ethnicity (Black vs. White (aOR = 1.43, p = 0.015)), older age (≥70 vs. 50–59 (aOR = 1.62, p = 0.006)), having insurance coverage (no vs. yes (aOR = 0.37 p = 0.005)), and lower income (≥USD 50,000 vs. <USD 25,000 (aOR = 0.70 p = 0.050)). These findings reveal a decrease over time in BSTU in Georgia, with existing differences between sociodemographic groups. Understanding these patterns helps in directing tailored programs for promoting CRC screening, especially among disadvantaged populations.

show abstract

The Phases of the Confrontation with Cancer

Kreitler

2019

Psycho-Oncology for the Clinician

View full text Add to dashboard Cite

Benefits and Risks of Colorectal Cancer Screening

Cited by 4 publications

References 58 publications

Evaluation of Colonoscopy and Sigmoidoscopy Utilization for Colorectal Cancer Screening in Georgia, USA

Evaluation of Colonoscopy and Sigmoidoscopy Utilization for Colorectal Cancer Screening in Georgia, USA

Evaluation of Blood Stool Test Utilization for Colorectal Cancer Screening in Georgia, USA

The Phases of the Confrontation with Cancer

Contact Info

Product

Resources

About